Christopher M. Flores

5.4k total citations · 1 hit paper
82 papers, 4.3k citations indexed

About

Christopher M. Flores is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Christopher M. Flores has authored 82 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cellular and Molecular Neuroscience, 34 papers in Molecular Biology and 30 papers in Physiology. Recurrent topics in Christopher M. Flores's work include Pain Mechanisms and Treatments (26 papers), Ion Channels and Receptors (25 papers) and Neuropeptides and Animal Physiology (18 papers). Christopher M. Flores is often cited by papers focused on Pain Mechanisms and Treatments (26 papers), Ion Channels and Receptors (25 papers) and Neuropeptides and Animal Physiology (18 papers). Christopher M. Flores collaborates with scholars based in United States, Belgium and Germany. Christopher M. Flores's co-authors include Kenneth Hargreaves, Theodore J. Price, Na Qin, Mary Lou Lubin, Tasha L. Hutchinson, Yan Wang, Michael P. Neeper, Raymond W. Colburn, Michael R. Brandt and Dennis J. Stone and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

Christopher M. Flores

82 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Attenuated Cold Sensitivity in TRPM8 Null Mice

2007 588 citations Mary Lou Lubin, Michael R. Brandt et al. profile →

Peers

Countries citing papers authored by Christopher M. Flores

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Flores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Flores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Flores more than expected).

Fields of papers citing papers by Christopher M. Flores

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Flores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Flores. The network helps show where Christopher M. Flores may publish in the future.

Co-authorship network of co-authors of Christopher M. Flores

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Flores. A scholar is included among the top collaborators of Christopher M. Flores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Flores. Christopher M. Flores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	JNJ-10450232 (NTM-006), A novel non-opioid with structural similarities to acetaminophen, produces relatively long-lasting analgesia after a single dose in patients undergoing 3rd molar extraction	Regulatory Toxicology and Pharmacology	Brenda Zimmerman, Peter Zannikos et al.	6
2	A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep)	Scandinavian Journal of Pain	Prasarn Manitpisitkul, Christopher M. Flores et al.	32
3	A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis	Scandinavian Journal of Pain	Arthur J. Mayorga, Christopher M. Flores et al.	34
4	Shivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibition	American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	Adithya Balasubramanian, Christopher M. Flores et al.	31
5	Mechanistic and functional differentiation of tapentadol and tramadol	Expert Opinion on Pharmacotherapy	Robert B. Raffa, Helmut Buschmann et al.	113
6	Validation of a Patch Clamp Screening Protocol That Simultaneously Measures Compound Activity in Multiple States of the Voltage-Gated Sodium Channel Nav1.2	Assay and Drug Development Technologies	Yi Liu, Christopher M. Flores et al.	8
7	Dynamic Mass Redistribution as a Means to Measure and Differentiate Signaling via Opioid and Cannabinoid Receptors	Assay and Drug Development Technologies	Ellen E. Codd, John R. Mabus et al.	21
8	An Integrated Multiassay Approach to the Discovery of Small-Molecule N-Type Voltage-Gated Calcium Channel Antagonists	Assay and Drug Development Technologies	Michael Finley, Mary Lou Lubin et al.	9
9	Development and Validation of a Secondary Screening Assay for TRPM8 Antagonists Using QPatch HT	Assay and Drug Development Technologies	Tasha L. Hutchinson, Na Qin et al.	12
10	TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons	Journal of Neuroscience	Na Qin, Michael P. Neeper et al.	312
11	Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons	Epilepsy Research	Yi Liu, George J. Yohrling et al.	32
12	N-Pyridin-3-yl- and N-quinolin-3-yl-benzamides: Modulators of Human Vanilloid Receptor 1 (TRPV1)	Bioorganic & Medicinal Chemistry Letters	James J. McNally, Mark A. Youngman et al.	4
13	A Nonadherent Cell-Based HTS Assay for N-Type Calcium Channel Using Calcium 3 Dye	Assay and Drug Development Technologies	Mary Lou Lubin, Matthew J. Todd et al.	14
14	Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion	BMC Neuroscience	Theodore J. Price, Gregory Dussor et al.	115
15	Pharmacological interactions between calcium/calmodulin-dependent kinase II α and TRPV1 receptors in rat trigeminal sensory neurons	Neuroscience Letters	Theodore J. Price, Christopher M. Flores et al.	42
16	Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism	Neuroscience	Jennifer L. Gibbs, Christopher M. Flores et al.	34
17	Activating transcription factor 3 mRNA is upregulated in primary cultures of trigeminal ganglion neurons	Molecular Brain Research	Gregory Dussor, Theodore J. Price et al.	15
18	Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron	Pain	Gregory Dussor, Kenneth Hargreaves et al.	68
19	Distribution and phenotype of cannabinoid type one receptor-expressing neurons in the trigeminal ganglion of the rat	The Society for Neuroscience Abstracts	Theodore J. Price, Deena Parghi et al.	2
20	Molecular Characterization of a Neuronal‐Specific Protein that Stimulates the Activity of Cdk5	Journal of Neurochemistry	K. Taranath Shetty, Stefanie Kaech et al.	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact